Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, MO, 63104, USA.
Department of Laboratory Medicine, Women & Children's Hospital of Linyi, Shandong Medical College, Linyi, 276000, People's Republic of China.
Mol Cancer. 2018 Apr 6;17(1):78. doi: 10.1186/s12943-018-0824-y.
SALL1 is a multi-zinc finger transcription factor that regulates organogenesis and stem cell development, but the role of SALL1 in tumor biology and tumorigenesis remains largely unknown.
We analyzed SALL1 expression levels in human and murine breast cancer cells as well as cancer tissues from different types of breast cancer patients. Using both in vitro co-culture system and in vivo breast tumor models, we investigated how SALL1 expression in breast cancer cells affects tumor cell growth and proliferation, metastasis, and cell fate. Using the gain-of function and loss-of-function strategies, we dissected the molecular mechanism responsible for SALL1 tumor suppressor functions.
We demonstrated that SALL1 functions as a tumor suppressor in breast cancer, which is significantly down-regulated in the basal like breast cancer and in estrogen receptor (ER), progesterone receptor (PR) and epidermal growth factor receptor 2 (HER2) triple negative breast cancer patients. SALL1 expression in human and murine breast cancer cells inhibited cancer cell growth and proliferation, metastasis, and promoted cell cycle arrest. Knockdown of SALL1 in breast cancer cells promoted cancer cell growth, proliferation, and colony formation. Our studies revealed that tumor suppression was mediated by recruitment of the Nucleosome Remodeling and Deacetylase (NuRD) complex by SALL1, which promoted cancer cell senescence. We further demonstrated that the mechanism of inhibition of breast cancer cell growth and invasion by SALL1-NuRD depends on the p38 MAPK, ERK1/2, and mTOR signaling pathways.
Our studies indicate that the developmental control gene SALL1 plays a critical role in tumor suppression by recruiting the NuRD complex and thereby inducing cell senescence in breast cancer cells.
SALL1 是一种多锌指转录因子,调节器官发生和干细胞发育,但 SALL1 在肿瘤生物学和肿瘤发生中的作用在很大程度上仍然未知。
我们分析了人源和鼠源乳腺癌细胞以及来自不同类型乳腺癌患者的癌症组织中 SALL1 的表达水平。我们通过体外共培养系统和体内乳腺癌模型,研究了乳腺癌细胞中 SALL1 的表达如何影响肿瘤细胞的生长和增殖、转移和细胞命运。通过功能获得和功能丧失策略,我们剖析了 SALL1 肿瘤抑制功能的分子机制。
我们证明 SALL1 在乳腺癌中作为肿瘤抑制因子发挥作用,在基底样乳腺癌和雌激素受体(ER)、孕激素受体(PR)和表皮生长因子受体 2(HER2)三阴性乳腺癌患者中显著下调。人源和鼠源乳腺癌细胞中 SALL1 的表达抑制了癌细胞的生长和增殖、转移,并促进了细胞周期停滞。乳腺癌细胞中 SALL1 的敲低促进了癌细胞的生长、增殖和集落形成。我们的研究表明,肿瘤抑制是通过 SALL1 募集核小体重塑和去乙酰化酶(NuRD)复合物介导的,该复合物促进了癌细胞衰老。我们进一步证明,SALL1-NuRD 抑制乳腺癌细胞生长和侵袭的机制依赖于 p38 MAPK、ERK1/2 和 mTOR 信号通路。
我们的研究表明,发育调控基因 SALL1 通过募集 NuRD 复合物在肿瘤抑制中发挥关键作用,从而诱导乳腺癌细胞衰老。